{"id":"NCT00594516","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","briefTitle":"Study on the Safety and Effectiveness of Switching Between Two Forms of Tapentadol in Patients With Chronic Low Back Pain","officialTitle":"A Randomized, Double-Blind, 2-Period, Crossover Study to Establish the Dose Equivalence and Direct Conversion Between Immediate Release (IR) and Extended-Release (ER) CG5503 in Subjects With Moderate-to-Severe, Chronic Low Back Pain","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-12","primaryCompletion":"2008-04","completion":"2008-05","firstPosted":"2008-01-15","resultsPosted":"2010-07-26","lastUpdate":"2015-04-15"},"enrollment":117,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Low Back Pain"],"interventions":[{"type":"DRUG","name":"tapentadol (CG5503) Immediate Release IR","otherNames":[]},{"type":"DRUG","name":"tapentadol (CG5503) Extended Release (ER)","otherNames":[]},{"type":"DRUG","name":"tapentadol (CG5503) Immediate Release (IR)","otherNames":[]}],"arms":[{"label":"001","type":"EXPERIMENTAL"},{"label":"002","type":"EXPERIMENTAL"}],"summary":"The objective of this study is to test the idea that the immediate-release (IR) form of tapentadol (CG5503) can be directly converted into an approximately equivalent total daily dose (TDD) of the extended-release (ER) form, and vice-versa, with equivalent safety and efficacy.","primaryOutcome":{"measure":"The Difference in the Mean Average Pain Intensity Score on an 11-point Numerical Rating Scale (NRS) During the Last 3 Days of Each Double-blind Treatment Period. (Difference Between Two DB Randomization Treatment Sequences)","timeFrame":"14 days for each cross-over period","effectByArm":[{"arm":"Tapentadol","deltaMin":0.1,"sd":null}],"pValues":[{"comp":"OG000","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":12},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["20119464"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":116},"commonTop":["Dizziness","Headache","Somnolence","Nausea","Fatigue"]}}